Glenmark Life Sciences Ltd
NSE:GLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Glenmark Life Sciences Ltd
NSE:GLS
|
IN |
|
M
|
Mitsubishi Chemical Group Corp
F:M3C0
|
JP |
|
H
|
Healthcare Trust Of America Inc
F:HT01
|
US |
|
Chesapeake Energy Corp
NASDAQ:CHK
|
US |
|
S
|
SGL Carbon SE
XMUN:SGL
|
DE |
|
Teleperformance SE
PAR:TEP
|
FR |
|
NTG Nordic Transport Group AS
F:NRSA
|
DK |
|
First Financial Corp
NASDAQ:THFF
|
US |
|
M&T Bank Corp
NYSE:MTB
|
US |
|
Helen of Troy Ltd
NASDAQ:HELE
|
BM |
|
Gujarat Narmada Valley Fertilizers & Chemicals Ltd
NSE:GNFC
|
IN |
|
Conduent Inc
NASDAQ:CNDT
|
US |
|
Golub Capital Bdc Inc
NASDAQ:GBDC
|
US |
Wall St Price Targets
GLS Price Targets Summary
Glenmark Life Sciences Ltd
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GLS's stock price target?
Not Available
GLS does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Glenmark Life Sciences Ltd?
Projected CAGR
12%
Over the last 4 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for Glenmark Life Sciences Ltd?
Projected CAGR
12%
Over the last 4 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 12%.
What is the Net Income forecast for Glenmark Life Sciences Ltd?
Projected CAGR
15%
Over the last 4 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 15%.
